Back to results
US 2020/0270271 A1Published application
Prodrugs of 2,4-pyrimidinediamine compounds and their uses
AssigneeRigel Pharmaceuticals, Inc.
InventorsRajinder Singh, Somasekhar Bhamidipati, Esteban Masuda, Thomas Sun, Valentino J. Stella
Life of this patent
Estimating the term…
Abstract
The present disclosure provides prodrugs of biologically active 2,4-pyrimidinediamine compounds, compositions comprising the prodrugs, intermediates and methods for synthesizing the prodrugs and methods of using the prodrugs in a variety of applications.
Claims25
A compound, comprising a 2,4-pyrimidinediamine moiety and a means for delivering the 2,4-pyrimidinediamine moiety in vivo.
A pharmaceutical composition comprising a means for delivering a therapeutic agent effective to inhibit Syk in vivo, and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.